x 

0 Activities
0 Activities
    • No Saved Activities
Page 2 of 2
Results 76 - 113 of 113
No image set
Hereditary Transthyretin Amyloidosis: Case Studies
No image set
hATTR Amyloidosis: You and Your Family
No image set
The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring
No image set
The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence
No image set
Advances in Multiple Sclerosis (AIMS) Primer: 3rd Edition
No image set
A Practical Guide to Rehabilitation in Multiple Sclerosis: 2nd Edition
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
castro-tff
Updates in SMA from Austin, Texas
No image set
Technology Improving SMA Patients’ Quality of Life
No image set
Nusinersen Treatment Outcomes in Later-Onset SMA
No image set
Patients with Severe SMA Need Additional Respiratory Management
Castro_02
Clear Expectations Needed in SMA Patient Management
Castro_01
Improvements in Quality of Life for Patients with Neuromuscular Diseases
9927-264x150
Updates in SMA and Gene Therapy from Copenhagen, Denmark
9920-264x150
The Changing Landscape of SMA–Updates from Copenhagen, Denmark
sma-icon
Are You Ready for Gene Replacement Therapy?
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9833-0001-icon
Urgency for Early Diagnosis and Treatment of SMA
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
9808-0003
SMA Updates from Los Angeles
9808-0002
Updates in SMA and Gene Therapy from Arlington, VA
aims icon-target
Targeting B-cells in Primary Progressive MS (PPMS)
aims icon-comorb
Comorbidities and Selection of DMTs
aims icon-gut
The Gut Microbiota in MS
aims icon-early
Early MS: Induction Therapy and Escalation Strategies
aims icon-vitamin
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
lgmw-05
A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT
lgmw-04
32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...
lgmw-03
A 60 y/o Male w/4-year History Of Shoulder Weakness
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Addressing Common Barriers to Adherence
9529-00028
Approach to Genetic Testing in Myopathies
9529-00014
Molecular Diagnosis of Limb-Girdle Muscle Weakness
Page 2 of 2

Search